X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (467) 467
ophthalmology (444) 444
humans (328) 328
male (232) 232
female (203) 203
animals (170) 170
subconjunctival injection (166) 166
bevacizumab (156) 156
middle aged (141) 141
surgery (131) 131
eye diseases (126) 126
aged (123) 123
subconjunctival (116) 116
adult (113) 113
glaucoma (108) 108
rabbits (102) 102
injections (99) 99
subconjunctival bevacizumab (95) 95
sense organs (90) 90
genetic structures (87) 87
intraocular pressure (87) 87
treatment outcome (86) 86
angiogenesis (83) 83
corneal neovascularization (80) 80
endothelial growth-factor (80) 80
conjunctiva (79) 79
injection (79) 79
cornea (78) 78
eye (77) 77
follow-up studies (71) 71
angiogenesis inhibitors - administration & dosage (70) 70
trabeculectomy (69) 69
mitomycin c (68) 68
macular edema (67) 67
vascular endothelial growth factor a - antagonists & inhibitors (64) 64
neovascularization (63) 63
visual acuity (62) 62
disease models, animal (61) 61
prospective studies (61) 61
vascular endothelial growth factor (61) 61
inflammation (59) 59
optical coherence tomography (57) 57
cataract (56) 56
pharmacology & pharmacy (56) 56
triamcinolone (56) 56
aged, 80 and over (54) 54
avastin (54) 54
care and treatment (53) 53
retrospective studies (51) 51
corneal neovascularization - drug therapy (50) 50
branch retinal vein occlusion (47) 47
conjunctiva - drug effects (47) 47
macular degeneration (47) 47
therapy (47) 47
subconjunctival bevacizumab injection (46) 46
drug delivery systems (45) 45
research (43) 43
retinoblastoma (43) 43
vitrectomy (43) 43
analysis (42) 42
postoperative complications (42) 42
topical bevacizumab (42) 42
inhibition (41) 41
intravitreal (41) 41
recurrent pterygium (41) 41
triamcinolone acetonide (41) 41
intravitreal bevacizumab (40) 40
pharmacokinetics (40) 40
administration, topical (39) 39
dexamethasone (38) 38
glaucoma - surgery (38) 38
blindness (37) 37
excision (37) 37
retinal nerve fiber layer (37) 37
expression (36) 36
mitomycin-c (36) 36
pterygium surgery (36) 36
adolescent (35) 35
angiogenesis inhibitors - therapeutic use (35) 35
myopia (35) 35
subconjunctival carboplatin (35) 35
children (34) 34
keratoconus (34) 34
antibodies, monoclonal, humanized - administration & dosage (33) 33
management (33) 33
quality of life (33) 33
diagnosis (32) 32
endophthalmitis (32) 32
heavy silicone oil (32) 32
risk factors (32) 32
antimicrobial effect (31) 31
case studies (31) 31
conventional silicone oil (31) 31
disability evaluation (31) 31
endophthalmitis agents (31) 31
injections, intraocular (31) 31
mean deviation (31) 31
modified deep anterior lamellar keratoplasty (31) 31
non-proliferative diabetic retinopathy (31) 31
pterygium recurrence (31) 31
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (591) 591
Korean (33) 33
French (12) 12
German (9) 9
Polish (1) 1
Spanish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Ophthalmic plastic and reconstructive surgery, ISSN 0740-9303, 11/2018, Volume 34, Issue 6, pp. 587 - 593
Purpose: To evaluate the role of transconjunctival triamcinolone acetonide (TA) injection in the management of upper eyelid retraction in thyroid eye disease.... 
SURGERY | MANAGEMENT | MUSCLE | OPHTHALMOLOGY | TOXIN TYPE-A | SUBCONJUNCTIVAL INJECTION | ORBITOPATHY | HYALURONIC-ACID GEL | GRAVES OPHTHALMOPATHY | Eye diseases | Dosage and administration | Research | Drug therapy | Triamcinolone | Index Medicus
Journal Article
American Journal of Ophthalmology, ISSN 0002-9394, 2013, Volume 156, Issue 3, pp. 616 - 622.e3
Journal Article
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, ISSN 0146-0404, 05/2017, Volume 58, Issue 5, pp. 2746 - 2754
PURPOSE. To determine in vitro release profiles, transcorneal permeation, and ocular injection characteristics of a voriconazole-containing thermogel suitable... 
CORNEAL THICKNESS | DIAGNOSIS | voriconazole | thermogel | sustained-release | AQUEOUS-HUMOR | MICROBIAL KERATITIS | OCULAR DRUG-DELIVERY | EPISCLERAL CYCLOSPORINE IMPLANT | keratomycosis | MYCOTIC KERATITIS | RABBITS | PLGA-PEG-PLGA | EQUINE ULCERATIVE KERATOMYCOSIS | subconjunctival | OPHTHALMOLOGY | INTRAVITREAL DELIVERY | equine
Journal Article
Journal Article
Drug Design, Development and Therapy, ISSN 1177-8881, 06/2015, Volume 9, pp. 3043 - 3050
Purpose: Dry eye is a chronic inflammatory ocular surface disease with high prevalence. The current therapies for dry eye remain to be unspecific and... 
Anti-VEGF | Dry eye | Ocular surface inflammation | Bevacizumab | Subconjunctival | CELLS | CYTOKINES | CHEMISTRY, MEDICINAL | anti-VEGF | dry eye | TEARS | ocular surface inflammation | DISEASE | bevacizumab | subconjunctival | SURFACE | PHARMACOLOGY & PHARMACY | OSMOLARITY | FLUORESCEIN | Bevacizumab - therapeutic use | Bevacizumab - adverse effects | Humans | Middle Aged | Goblet Cells - drug effects | Male | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Meibomian Glands - pathology | Young Adult | Angiogenesis Inhibitors - administration & dosage | Conjunctiva - pathology | Regional Blood Flow - drug effects | Aged, 80 and over | Angiogenesis Inhibitors - therapeutic use | Adult | Female | Cornea - pathology | Angiogenesis Inhibitors - adverse effects | Tears - drug effects | Bevacizumab - administration & dosage | Dry Eye Syndromes - drug therapy | Treatment Outcome | Injections | Adolescent | Aged | Conjunctiva - blood supply | Drug therapy | Dry eye syndromes | Cornea | Cytology | Vascularization | Acuity | Eye | Angiogenesis | Pain | Eye (anatomy) | Breakup | Blood pressure | Safety | Vascular endothelial growth factor | Signs and symptoms | Cytokines | Desiccants | Visual observation | Visual acuity | Inflammation | Injection | FDA approval | Gene expression | Hospitals | Cellular biology | Eye diseases | Intraocular pressure | Index Medicus
Journal Article
Retina, ISSN 0275-004X, 2014, Volume 34, Issue 5, pp. 935 - 942
Purpose: To determine whether the application of subconjunctival 2% lidocaine/0.1% methylparaben for anesthesia may reduce rates of endophthalmitis after... 
Endophthalmitis | Anesthesia | Antibacterial | Intravitreal injection | Lidocaine | Subconjunctival | BACTERIA | TOPICAL ANESTHETICS | LOCAL-ANESTHETICS | subconjunctival | OPHTHALMOLOGY | antibacterial | AGENTS | endophthalmitis | intravitreal injection | lidocaine | anesthesia | Lidocaine - pharmacology | Staphylococcus epidermidis - drug effects | Intravitreal Injections | Humans | Colony Count, Microbial | Eye Infections, Bacterial - drug therapy | Preservatives, Pharmaceutical - pharmacology | Anesthetics, Local - pharmacology | Eye Infections, Bacterial - microbiology | Bacteriological Techniques | Retrospective Studies | Staphylococcal Infections - microbiology | Anesthetics, Local - administration & dosage | Endophthalmitis - drug therapy | Parabens - administration & dosage | Streptococcal Infections - microbiology | Staphylococcal Infections - drug therapy | Staphylococcus aureus - isolation & purification | Staphylococcus epidermidis - isolation & purification | Lidocaine - administration & dosage | Viridans Streptococci - isolation & purification | Parabens - pharmacology | Endophthalmitis - microbiology | Viridans Streptococci - drug effects | Streptococcal Infections - drug therapy | Anti-Bacterial Agents - pharmacology | Preservatives, Pharmaceutical - administration & dosage | Staphylococcus aureus - drug effects | Anti-Bacterial Agents - administration & dosage | Index Medicus
Journal Article
Journal of Drug Delivery Science and Technology, ISSN 1773-2247, 02/2019, Volume 49, pp. 556 - 562
Ocular drug delivery, specifically protein drug delivery to the posterior segment of the eye, remains a challenge. The purpose of this study was to prepare a... 
Posterior segment | Biocompatibility | PLGA-PEG-PLGA hydrogel | Subconjunctival injection | Insulin
Journal Article
Journal of Pharmaceutical Sciences, ISSN 0022-3549, 07/2012, Volume 101, Issue 7, pp. 2353 - 2363
Previous magnetic resonance imaging (MRI) studies to investigate the routes of penetration and barriers in ocular delivery have provided insights into the... 
imaging methods | ophthalmic drug delivery | subconjunctival injection | MRI | pharmacokinetics | clearance | transscleral delivery | intravitreal injecti